机译:2型糖尿病精准医学的全球概述
Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences Malmoe, Lund University Diabetes Centre, Skane University Hospital, Malmoe, Sweden;
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K,Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K;
Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA,Programs in Metabolism and Medical and Population Genetics, Broad Institute, Cambridge, MA,Department of Medicine, Harvard Medical School, Boston, MA;
Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences Malmoe, Lund University Diabetes Centre, Skane University Hospital, Malmoe, Sweden,Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K,Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA,Department of Public Health and Clinical Medicine, Umea University, Umea, Sweden;
机译:用于治疗2型糖尿病的药物和1型胰岛素的胰岛素,低资源环境中的2型糖尿病:世界卫生组织第二和第三线药物和血糖控制类型的胰蛋白酶概况和胰岛素的概要 非妊娠成年人的水平患有糖尿病。
机译:网络医学和2型糖尿病:疾病机制见解和精密药物指南
机译:精密医学在2型糖尿病(T2DM)中的重要性:来自药物发生和药物观念
机译:迈向物联网的精确行为医学:针对1型糖尿病的自我管理工具的迭代设计和优化
机译:遗传检测在糖尿病精密药物中的作用
机译:2型糖尿病精准医学的全球概述
机译:生活方式和精准糖尿病医学:基因组学将通过生活方式疗法帮助优化2型糖尿病的预测,预防和治疗吗?